Executive Brief: Competitive Landscape and Strategic Developments in the Middle East Viral Inactivation Market
The Middle EAST Viral Inactivation Market was valued at USD 0.75 billion in 2024 and is projected to reach USD 1.50 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several key factors, including the increasing prevalence of viral infections, heightened regulatory scrutiny, and the growing demand for safe and effective therapeutic solutions. The rising...
0 التعليقات 0 المشاركات 48 مشاهدة 0 معاينة